Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

novartis_outside_1

Novartis’ Sandoz scores EU approval for Remicade biosimilar

May 24, 2018 Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma

The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …
News
merck_and_co

MSD’s Keytruda scores impressive first-line lung cancer data

May 24, 2018 Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …
News
handshake_2

Vifor Fresenius snap up rights to Cara’s itch therapy

May 23, 2018 Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …
News
fda2outsideweb

Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer

May 23, 2018 Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer

Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …
News
512px-kratom_leaves_3

FDA reprimands suppliers of opioid substitute kratom products

May 23, 2018 Research and Development, Sales and Marketing FDA, kratom, opioid crisis, opioids, pharma

The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …
News
takeda_tokyo_hq

Takeda begins to shore up finances with $280m divestment

May 23, 2018 Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …
News
landing-hero-images1

ViiV’s two-drug regimen gets EU approval for HIV-1

May 22, 2018 Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma

ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …
News
pills_shot

Nabriva closes in on bringing new class of antibiotic to market

May 22, 2018 Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …
News
gilead-sciences

Gilead expands operations in Cork, Ireland

May 21, 2018 Manufacturing and Production, Sales and Marketing Gilead, Ireland, biotech, drugs, pharma, pharmaceutical

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …
News
shutterstock_349943306

Clinical trials, Brexit and the question of ‘full alignment’

May 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit, clinical trials, feature, pharma

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …
Feature
european_commission_web

EMA review confirms risks of Abbvie and Biogen’s Zinbryta outweigh benefits

May 21, 2018 Research and Development, Sales and Marketing EMA, Europe, European Commission, PRAC, multiple sclerosis, pharma, zinbryta

The EMA has judged that the benefits offered by Zinbryta (daclizumab), Abbvie and Biogen’s humanised IgG1 monoclonal antibody for the …
News
roche

Roche’s Hemlibra stakes claim to be haemophilia market leader

May 21, 2018 Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …
News
astrazeneca_sign_sky

FDA approves AZ’s Lokelma for hyperkalaemia

May 21, 2018 Sales and Marketing AstraZeneca, FDA, Lokelma, hyperkalaemia, pharma

The FDA has revealed its decision to approve AstraZeneca’s oral potassium-removing agent Lokelma (sodium zirconium cyclosilicate) for the treatment of …
News
greek_parliament

Investigation of kickbacks in Greece sputters to halt

May 21, 2018 Sales and Marketing Greece, Novartis, biotech, drugs, pharma, pharmaceutical

Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians. The case has dominated …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026